Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

PRESSURE BIOSCIENC : Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update

11/14/2008 | 04:15pm US/Eastern

SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its third quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Monday, November 17, 2008

Time: 4:30 p.m. Eastern Standard Time (EST)

To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com

    To attend this teleconference via telephone:
    Dial-in: (800) 344-6491
    Participant code: 3034253

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends, and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

    Investor Contacts:
    Richard T. Schumacher, President & CEO
    Edward H. Myles, Senior Vice President of Finance & CFO
    Pressure BioSciences, Inc.
    (T) 508-230-1828

SOURCE Pressure BioSciences, Inc.

React to this article
Latest news on PRESSURE BIOSCIENCES, INC.
08/18 PRESSURE BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered ..
08/14 PRESSURE BIOSCIENCES : Management's Discussion and Analysis of Financial Conditi..
08/03 PRESSURE BIOSCIENCES INC : SeeThruEquity Issues Update on Pressure BioSciences (..
07/30 PRESSURE BIOSCIENCES INC : Pressure BioSciences (PBIO) Showing Significant Poten..
07/28 PRESSURE BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered ..
07/15 PRESSURE BIOSCIENCES' : PCT Platform a Key Workflow Component in Study to Discov..
07/08 PRESSURE BIOSCIENCES : Better Classification of Prostate Cancer Tissue Biopsy Sa..
07/07 PRESSURE BIOSCIENCES' : PCT Platform Results in a Promising New Method for Impro..
06/26 PRESSURE BIOSCIENCES : Changes in Registrant's Certifying Accountant, Financial ..
06/12 PRESSURE BIOSCIENCES INC : Critical Advancements in Bioscience Make for Breakthr..